The Gordon and Betty Moore Foundation’s Diagnostic Excellence Initiative recently announced a funding opportunity soliciting novel ideas and approaches for developing new clinical quality measures to improve diagnosis, specifically targeting three major categories of disease: acute vascular events (such as stroke and myocardial infarction), infections (such as sepsis and pneumonia) and cancer (such as lung and colorectal). Successfully funded proposals will form our second cohort of grantees in this area. The first cohort has already begun working on promising and interesting projects.
The foundation’s Diagnostic Excellence Initiative addresses a pressing need to improve diagnostic performance. Over the last few decades, significant progress has been made in medication safety and therapeutics, but work has been slow to address diagnosis. Twelve million Americans experience a diagnostic error each year, and it is likely that each of us will experience a diagnostic error in our lifetime. Delayed or missed diagnoses result in delays in treatment, allow undiagnosed conditions to persist or even progress and worsen outcomes.
Novel Ideas and Approaches for Developing New Clinical Measures to Improve Diagnosis
Application deadline: May 4, 2020
Diagnostic errors, particularly inaccurate or delayed diagnoses, are beginning to receive more attention from the field of health care. In addition to the foundation’s request for proposals, our partners are sharing funding opportunities of their own:
Society to Improve Diagnosis Seed Grant Program
Application deadline: March 30, 2020
More information: dxqiseedgrant@ImproveDiagnosis.org
ABMS Visiting Scholars Program
Application deadline: June 5, 2020
More information: https://www.abms.org/initiatives/visiting-scholars-program/who-should-apply/